The separate daily application of tacalcitol 4 μg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 μg/g and betamethasone dipropionate 0.5 mg/g

Giornale Italiano di Dermatologia e Venereologia

Volumn 146, Issue 4, 2011, Pages 295-299

  Calzavara Pinton, P ^a   Rossi, M T ^a   Sala, R ^a   Venturini, M ^a  

^a Department of Dermatology Spedali Civili ^*  (Italy)

Author keywords

Adrenal cortex hormones; Clinical trial; Psoriasis; Vitamin D

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; BIDIEN; BUDESONIDE; TACALCITOL; TICLAPSOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREAM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; EVENING DOSAGE; FEMALE; HUMAN; MALE; MORNING DOSAGE; OINTMENT; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SKIN DEFECT; SKIN EXFOLIATION; SKIN IRRITATION; SKIN PRURITUS; SKINFOLD THICKNESS; TOPICAL TREATMENT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 80755175313     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Peeters P, Ortonne JP, Sitbon R, Guignard E. Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris. Dermatology 2005;211:139-45. (Pubitemid 41160250)
2. Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C et al. Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian psoriasis expert panel. J Cut Med Surg 2004;8:321-37. (Pubitemid 41542422)
3. Fredriksonn T, Saide L. A double-blind trial of budesonide and betamethasone-17, 21-dipropionate in psoriasis. Curr Med Res Opin 1982;8:171-7.
4. Scott M, Malmsten LA, Thelin I. Effect on plasma cortisol level and urinary cortisol excretion in healthy volunteers, after application of three different topical steroid ointments under occlusion. Acta Derm Venereol (Stockh) 1981;61:543-6. (Pubitemid 12246791)
5. Fredriksson, T, Pettersson, U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978;157:238-44. (Pubitemid 8387357)
6. Veien NK, Bjerke JR, Rossmann-Ringdahl I, Jakobsen HB.Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. Br J Dermatol 1997;137:581-6. (Pubitemid 27469510)
7. Langner A, Stapor W, Ambroziak M. Vitamin d3 metabolites and analogies in the treatment of scalp psoriasis. J Dermatol Treat 1998;9:31-45.
8. Kragballe K, Barnes L, Hamberg KJ, Hutchinson P, Murphy F, Møller S et al. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br J Dermatol 1998;139:649-54. (Pubitemid 28474311)
9. Schmidt H, Hjorth N, Slade L. A double-blind trial of budesonide oitnment and betamethasone-17-valerate ointment in psoriasis. J Int Med Res 1981;9:236-8. (Pubitemid 11104721)
10. Scott U, Dunn CJ, Goa KL. Calcipotriol ointment. A review of its use in the management of psoriasis. Am J Clin Dermatol 2001;2:95-120. (Pubitemid 32592528)
11. Van de Kerkhof PC, Berth-Jones J, Griffiths CE, Harrison PV, Hönigsmann H, Marks R et al. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis. Br J Dermatol 2002;146:414-22. (Pubitemid 34603813)
12. Parslew R, Traulsen J. Efficacy and local safety of a calcipotriol/betamethasone dipropionate ointment in elderly patients with psoriasis vulgaris. Eur J Dermatol 2005;15:37-9. (Pubitemid 40254621)
13. Ortonne JP, Kaufmann R, Lecha M, Goodfield M. Efficacy of treatment with calcipotriol/ bethametasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomized, double blind trial. Dermatology 2004;209:308-63.
14. Koo J, Blum RR, Lebwohl M. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: Short- and long-term outcomes. J Am Acad Dermatol 2006;55:637-41. (Pubitemid 44436646)
15. Lamba S, Lebwohl M. combination therapy with vitamin D analogues. Br J Dermatol 2001;144(Suppl 58):27-32.
16. Kowalzick L. Clinical experience with topical calcitriol (1.25-dihydroxyvitamin D3) in psoriasis. Br J Dermatol 2001; 144(Suppl 58):21-5. (Pubitemid 33756011)
17. Lebwohl M, Siskin SB, Epinette W, Breneman D, Funicella T, Kalb R et al. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 1996;35:268-9.